259 related articles for article (PubMed ID: 27093554)
21. Prion protein glycosylation.
Lawson VA; Collins SJ; Masters CL; Hill AF
J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
[TBL] [Abstract][Full Text] [Related]
22. Copper binding to prion octarepeat peptides, a combined metal chelate affinity and immunochemical approaches.
Todorova-Balvay D; Simon S; Créminon C; Grassi J; Srikrishnan T; Vijayalakshmi MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):75-82. PubMed ID: 15722047
[TBL] [Abstract][Full Text] [Related]
23. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro.
Nishina KA; Deleault NR; Mahal SP; Baskakov I; Luhrs T; Riek R; Supattapone S
Biochemistry; 2006 Nov; 45(47):14129-39. PubMed ID: 17115708
[TBL] [Abstract][Full Text] [Related]
24. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Prasad KN; Bondy SC
Curr Aging Sci; 2019; 11(4):216-225. PubMed ID: 30636622
[TBL] [Abstract][Full Text] [Related]
25. Prion protein protects mice from lethal infection with influenza A viruses.
Chida J; Hara H; Yano M; Uchiyama K; Das NR; Takahashi E; Miyata H; Tomioka Y; Ito T; Kido H; Sakaguchi S
PLoS Pathog; 2018 May; 14(5):e1007049. PubMed ID: 29723291
[TBL] [Abstract][Full Text] [Related]
26. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
Hornemann S; Glockshuber R
J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
[TBL] [Abstract][Full Text] [Related]
27. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein.
Thackray AM; Madec JY; Wong E; Morgan-Warren R; Brown DR; Baron T; Bujdoso R
Biochem J; 2003 Feb; 370(Pt 1):81-90. PubMed ID: 12429022
[TBL] [Abstract][Full Text] [Related]
28. Cellular prion proteins in human platelets show a phenotype different to those in brain tissues.
Kuczius T; Kleinert J; Karch H; Sibrowski W; Kelsch R
J Cell Biochem; 2011 Mar; 112(3):954-62. PubMed ID: 21328470
[TBL] [Abstract][Full Text] [Related]
29. Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.
Pan T; Wong P; Chang B; Li C; Li R; Kang SC; Wisniewski T; Sy MS
J Virol; 2005 Jan; 79(2):934-43. PubMed ID: 15613322
[TBL] [Abstract][Full Text] [Related]
30. Insights into the physiological function of cellular prion protein.
Martins VR; Mercadante AF; Cabral AL; Freitas AR; Castro RM
Braz J Med Biol Res; 2001 May; 34(5):585-95. PubMed ID: 11323744
[TBL] [Abstract][Full Text] [Related]
31. The structure function relationship for the Prion protein.
Deignan ME; Prior M; Stuart LE; Comerford EJ; McMahon HE
J Alzheimers Dis; 2004 Jun; 6(3):283-9. PubMed ID: 15201483
[TBL] [Abstract][Full Text] [Related]
32. Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner.
Ellis V; Daniels M; Misra R; Brown DR
Biochemistry; 2002 Jun; 41(22):6891-6. PubMed ID: 12033920
[TBL] [Abstract][Full Text] [Related]
33. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
34. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
35. Identification of a homology-independent linchpin domain controlling mouse and bank vole prion protein conversion.
Burke CM; Mark KMK; Walsh DJ; Noble GP; Steele AD; Diack AB; Manson JC; Watts JC; Supattapone S
PLoS Pathog; 2020 Sep; 16(9):e1008875. PubMed ID: 32898162
[TBL] [Abstract][Full Text] [Related]
36. The cellular prion protein binds copper in vivo.
Brown DR; Qin K; Herms JW; Madlung A; Manson J; Strome R; Fraser PE; Kruck T; von Bohlen A; Schulz-Schaeffer W; Giese A; Westaway D; Kretzschmar H
Nature; 1997 Dec 18-25; 390(6661):684-7. PubMed ID: 9414160
[TBL] [Abstract][Full Text] [Related]
37. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
38. Prion metal interaction: is prion pathogenesis a cause or a consequence of metal imbalance?
Rana A; Gnaneswari D; Bansal S; Kundu B
Chem Biol Interact; 2009 Oct; 181(3):282-91. PubMed ID: 19660443
[TBL] [Abstract][Full Text] [Related]
39. Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma.
Williams WM; Stadtman ER; Moskovitz J
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):161-8. PubMed ID: 15043713
[TBL] [Abstract][Full Text] [Related]
40. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
